Effectiveness and Safety of a Novel Care Model for the Management of Type 2 Diabetes at 1 Year: An Open-Label, Non-Randomized, Controlled Study

Share This Post

URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104272/

Journal: Diabetes Therapy

Publication Date: 02/2018

Summary: Treatments for type 2 diabetes (T2D) have improved, yet T2D and being overweight are still significant public health concerns. Blood sugar in patients with T2D can improve quickly when patients eat significantly fewer dietary carbohydrates. However, this demands careful medicine management by doctors, and patients need support and frequent contact with health providers to sustain this way of living. The purpose of this study was to evaluate if a new care model with very low dietary carbohydrate intake and continuous supervision by a health coach and doctor could safely lower HbA1c, weight and need for medicines after 1 year in adults with T2D. 262 adults with T2D volunteered to participate in this continuous care intervention (CCI) along with 87 adults with T2D receiving usual care (UC) from their doctors and diabetes education program. After 1 year, patients in the CCI, on average, lowered HbA1c from 7.6 to 6.3%, lost 12% of their body weight, and reduced diabetes medicine use. 94% of patients who were prescribed insulin reduced or stopped their insulin use, and sulfonylureas were eliminated in all patients. Participants in the UC group had no changes to HbA1c, weight or diabetes medicine use over the year. These changes in CCI participants happened safely while dyslipidemia and markers of inflammation and liver function improved. This suggests the novel care model studied here using dietary carbohydrate restriction and continuous remote care can safely support adults with T2D to lower HbA1c, weight, and medicine use.

Key Takeaways

Type 2 diabetics who utilized a low carbohydrate diet with supervision from a health coach were able to effectively lose 12% of body weight, reduce HbA1C by an average of 1.3%, and reduce their diabetic medication use.

Low Carb Diets Put Diabetes In Remission

Share This Post

Subscribe To Our Newsletter

Get Fun Carnivore Updates and inspirations

Leave a Comment

Your email address will not be published.

More To Explore

The ketone body β-hydroxybutyrate mitigates ILC2-driven airway inflammation by regulating mast cell function

URL: https://www.cell.com/cell-reports/fulltext/S2211-1247(22)01278-5?Journal: Cell ReportsPublication Date: 09/2022Summary: Ketone bodies are increasingly understood to have regulatory effects on immune cell function, with β-hydroxybutyrate (BHB) exerting a predominantly anti-inflammatory response. Dietary strategies to increase endogenous ketone body availability such as the ketogenic diet (KD) have recently been shown to alleviate inflammation of the respiratory tract. However, the role

Ketogenic diet for weight loss

URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371871/Journal: Canadian Family PhysicianPublication Date: 12/2018Summary: Ketogenic diets can help patients lose about 2 kg more than low-fat diets do at 1 year, but higher-quality studies show no difference. Weight loss peaks at about 5 months but is often not sustained. Individual weight change can vary from losing 30 kg to gaining 10 kg

Do You Want To Achieve your Optimal Health?

Join us for a free 30-date trial. Cancel Anytime.